Phibro Animal Health Raises FY2026 Adj EPS Guidance from $2.52-$2.70 to $2.64-$2.81 vs $2.63 Est; Affirms FY2026 Sales Guidance of $1.430B-$1.480B vs $1.459B Est
Benzinga Newsdesk 12 months ago
NewsGuidance
Phibro Animal Health (NASDAQ:PAHC) raises FY2026 Adj EPS guidance from $2.52-$2.70 to $2.64-$2.81 vs $2.63 analyst estimate. Affirms FY2026 sales outlook from $1.430 billion-$1.480 billion to $1.430 billion-$1.480
Phibro Animal Health (NASDAQ:PAHC) raises FY2026 Adj EPS guidance from $2.52-$2.70 to $2.64-$2.81 vs $2.63 analyst estimate. Affirms FY2026 sales outlook from $1.430 billion-$1.480 billion to $1.430 billion-$1.480 billion vs $1.459 billion estimate.